Summary
The presence of anti-“a-component” antibody was examined in sera of 4 groups of patients with or without anti-insulin antibody, using 125 I-a-component and the polyethylene glycol precipitation method. 125I-a-component crossreacted with insulin antibody. This cross-reactivity was abolished after preincubation of these sera with monocomponent insulin. The specific anti-“a-component” antibody could be estimated in this procedure. After preincubation with monocomponent insulin, significant binding of 125I-a-component was demonstrated in sera of most patients treated with ordinary commercial insulin, but not in sera of 2 hypoglycemic patients suspected of an insulin autoimmune syndrome. Some cases treated with commercial insulin for less than one year and all cases treated with monocomponent insulin for 7–10 months did not have significant anti-“a-component” antibody. The test for the presence of anti-“a-component” antibody is not definitive but if positive it differentiates “auto-antibodies” from the antibodies produced by injections of commercial insulin.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Hirata, Y., Ishizu, H., Ouchi, N., Motomura, S., Abe, M., Hara, Y., Wakasugi, H., Takahashi, I., Takano, H., Tanaka, M., Kawano, H., Kanesaki, T.: Insulin autoimmunity in a case with spontaneous hypoglycemia. J. Japan Diab. Soc. 13, 312–319 (1970)
Hirata, Y., Arimachi, M.: Insulin autoimmune syndrome-the second case. J. Japan Diab. Soc. 15, 187–192 (1972)
Følling, I., Norman, N.: Hyperglycemia, hypoglycemie attacks, and production of anti-insulin antibodies without previous known immunization. Immunological and functional studies in a patient. Diabetes 21, 814–826 (1972)
Nakagawa, S., Suda, S., Kudo, M., Kawasaki, M.: A new type of hypoglycemia in a new born infant. Diabetologia 9, 367–375 (1973)
Ohneda, A., Matsuda, K., Sato, M., Yamagata, S., Sato, T.: Hypoglycemia due to apparent antibodies to insulin. Characterization of insulin-binding protein. Diabetes 23, 41–50 (1974)
Hirata, Y., Nishimura, H., Tominaga, M., Oguchi, T., Nakamura, Y.: Insulin autoimmunity in a case with mild diabetes. The third case of insulin-autoimmune syndrome. J. Japan Diab. Soc. 15, 336–342 (1972)
Sato, T., Saito, T., Honma, K., Ono, H., Yasuda, K., Torikai, T.: A case with considerable hyperinsulinemia and decreased glucose tolerance. J. Japan Diab. Soc. 15 (Suppl.), 176 (1972)
Nakano, M., Ito, M., Yamamoto, T., Hamazaki, T.: A case of insulin autoimmune syndrome followed-up with steroid therapy. J. Japan Diab. Soc. 17 (Suppl., 143 (1974)
Schlichtkrull, J., Brange, J., Christiansen, Aa. H., Hallund, O., Heding, L. G., Jörgensen, K. H.: Clinical aspects of insulin-antigenicity. Diabetes 21 (Suppl. 2), 649–656 (1972)
Schlichtkrull, J.: Monocomponent insulin and its clinical implications. Manuscript of paper to be read to the insulin study circle, Tokyo Oct., 1973
Schlichtkrull, J.: Antibodies to components of insulin. Lecture held at the Royal Society of Medicine's Meeting, London Feb., 1974
Morgan, C. R., Lazarow, A.: Immunoassay of insulin: Two antibody system. Plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes 12, 115–126 (1963)
Desbuquois, B., Aurbach, G. D.: Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimrmmoassays. J. clin. Endocr. 33, 732–738 (1971)
Nakagawa, S., Nakayama, H., Sasaki, T., Yoshino, K., Yu, Y. Y., Shinozaki, K., Aoki, S., Mashimo, K.: The determination of serum free insulin levels in the insulin-treated patients. J. Japan Diab. Soc. 15, 403–408 (1972)
Kenbo, T., Hirata, Y.: Immunological study of insulin antibodies in the sera of 14 cases of insulin autoimmune syndrome. J. Japan Diab. Soc. 17 (Suppl.), 145 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kawazu, S., Kanazawa, Y., Kajinuma, H. et al. Demonstration of anti-“a-component” antibody — A possible means to differentiate patients with auto-antibodies to endogenous insulin from insulin-treated patients. Diabetologia 11, 169–173 (1975). https://doi.org/10.1007/BF00422317
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00422317